XML 50 R32.htm IDEA: XBRL DOCUMENT v3.24.0.1
SHAREHOLDERS' EQUITY (Tables)
12 Months Ended
Dec. 31, 2023
Equity [Abstract]  
Schedule of employee and non-employee shares options activity
 
 
Number
   
Weighted
average
exercise
price
   
Weighted
average
remaining
contractual
life (years)
   
Aggregate
intrinsic
value (in
thousands)
 
Options outstanding at the beginning of the year
   
43,994
   
$
41.27
     
4.39
   
$
-
 
Granted
   
-
     
-
     
-
     
-
 
Exercised
   
-
     
-
     
-
     
-
 
Forfeited
   
(10,823
)
   
52.78
     
-
     
-
 
 
                               
Options outstanding at the end of the year
   
33,171
   
$
37.51
     
4.39
   
$
-
 
 
                               
Options exercisable at the end of the year
   
33,171
   
$
37.51
     
4.39
   
$
-
 
Schedule of employee and non-employee RSUs activity
 
 
Number of
shares
underlying
outstanding
RSUs
   
Weighted-
average
grant date
fair value
 
Unvested RSUs at the beginning of the year
   
2,755,057
     
1.16
 
Granted
   
2,258,370
     
0.66
 
Vested
   
(1,109,200
)
   
1.14
 
Forfeited
   
(131,813
)
   
1.13
 
 
               
Unvested RSUs at the end of the year
   
3,772,414
     
0.87
 
Schedule of options and RSUs outstanding
Range of exercise price
 
Options and
RSUs
Outstanding
as of
December 31,
2023
 
 
Weighted
average
remaining
contractual
life
(years) (1)
 
 
Options
Exercisable
as of
December 31,
2023
 
 
Weighted
average
remaining
contractual
life
(years) (1)
 
RSUs only
 
 
3,772,414
 
 
 
-
 
 
 
-
 
 
 
-
 
$5.37 
 
 
12,425
 
 
 
5.24
 
 
 
12,425
 
 
 
5.24
 
$20.42- $33.75 
 
 
12,943
 
 
 
4.35
 
 
 
12,943
 
 
 
4.35
 
$50-$52.5 
 
 
6,230
 
 
 
3.46
 
 
 
6,230
 
 
 
3.46
 
$182.5-$524.25 
 
 
1,573
 
 
 
1.65
 
 
 
1,573
 
 
 
1.65
 
 
 
 
3,805,585
 
 
 
4.39
 
 
 
33,171
 
 
 
4.39
 
Schedule of non-cash share-based compensation expense
 
 
Year Ended December 31,
 
 
 
2023
   
2022
   
2021
 
Cost of revenue
 
$
9
   
$
16
   
$
10
 
Research and development, net
   
157
     
94
     
55
 
Sales and marketing
   
381
     
250
     
171
 
General and administrative
   
781
     
633
     
597
 
 
                       
Total
 
$
1,328
   
$
993
   
$
833
 
Schedule of warrants outstanding and exercisable
Issuance date
 
Warrants
outstanding
   
Exercise price
per warrant
   
Warrants
outstanding
and
exercisable
 
Contractual
term
 
 
(number)
         
(number)
 
 
December 31, 2015 (1)
   
4,771
   
$
7.500
     
4,771
 
See footnote (1)
December 28, 2016 (2)
   
1,908
   
$
7.500
     
1,908
 
See footnote (1)
February 25, 2019 (5)
   
45,600
   
$
7.187
     
45,600
 
February 21, 2024
April 5, 2019 (6)
   
408,457
   
$
5.140
     
408,457
 
October 7, 2024
April 5, 2019 (7)
   
49,015
   
$
6.503
     
49,015
 
April 3, 2024
June 5, 2019, and June 6, 2019 (8)
   
1,464,665
   
$
7.500
     
1,464,665
 
June 5, 2024
June 5, 2019 (9)
   
87,880
   
$
9.375
     
87,880
 
June 5, 2024
June 12, 2019 (10)
   
416,667
   
$
6.000
     
416,667
 
December 12, 2024
June 10, 2019 (11)
   
50,000
   
$
7.500
     
50,000
 
June 10, 2024
February 10, 2020 (12)
   
28,400
   
$
1.250
     
28,400
 
February 10, 2025
February 10, 2020 (13)
   
105,840
   
$
1.563
     
105,840
 
February 10, 2025
July 6, 2020 (14)
   
448,698
   
$
1.760
     
448,698
 
January 2, 2026
July 6, 2020 (15)
   
296,297
   
$
2.278
     
296,297
 
January 2, 2026
December 8, 2020 (16)
   
586,760
   
$
1.340
     
586,760
 
June 8, 2026
December 8, 2020 (17)
   
108,806
   
$
1.792
     
108,806
 
June 8, 2026
February 26, 2021 (18)
   
5,460,751
   
$
3.600
     
5,460,751
 
August 26, 2026
February 26, 2021 (19)
   
655,290
   
$
4.578
     
655,290
 
August 26, 2026
September 29, 2021 (20)
   
8,006,759
   
$
2.000
     
8,006,759
 
March 29, 2027
September 29, 2021 (21)
   
960,811
   
$
2.544
     
960,811
 
September 27, 2026
 
   
19,187,375
             
19,187,375